$2.58 Billion is the total value of Redmile Group, LLC's 70 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 21.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | $290,371,000 | -9.6% | 12,957,222 | 0.0% | 11.26% | -8.1% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $226,748,000 | -4.7% | 21,719,191 | -2.0% | 8.80% | -3.2% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $132,398,000 | +6.2% | 1,899,545 | +0.1% | 5.14% | +7.9% |
| ARGX | Sell | ARGENX SEsponsored adr | $98,863,000 | -32.4% | 280,026 | -27.4% | 3.84% | -31.3% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $94,176,000 | +283.1% | 4,508,204 | +46.9% | 3.65% | +289.0% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $85,579,000 | +71.6% | 2,370,614 | +44.6% | 3.32% | +74.3% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $84,465,000 | +18.0% | 1,772,987 | -4.2% | 3.28% | +19.8% |
| LIVN | Sell | LIVANOVA PLC | $78,001,000 | -23.1% | 1,536,362 | -5.4% | 3.03% | -21.9% |
| IGMS | IGM BIOSCIENCES INC | $75,823,000 | +26.1% | 3,334,355 | 0.0% | 2.94% | +28.1% | |
| ONEM | Sell | 1LIFE HEALTHCARE INC | $70,103,000 | +97.7% | 4,087,625 | -9.6% | 2.72% | +100.8% |
| REPL | REPLIMUNE GROUP INC | $62,954,000 | -1.2% | 3,645,309 | 0.0% | 2.44% | +0.4% | |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $62,624,000 | +22.0% | 2,876,637 | +10.3% | 2.43% | +23.9% |
| ISEE | Buy | IVERIC BIO INC | $60,994,000 | +317.4% | 3,399,900 | +123.8% | 2.37% | +324.0% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $55,803,000 | -0.0% | 1,985,151 | -4.1% | 2.16% | +1.6% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $55,001,000 | +192.3% | 2,973,029 | +107.8% | 2.13% | +196.7% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $54,176,000 | +261.2% | 1,591,085 | +0.2% | 2.10% | +266.7% |
| VERV | Sell | VERVE THERAPEUTICS INC | $51,701,000 | +84.5% | 1,505,126 | -17.9% | 2.00% | +87.4% |
| RGNX | Sell | REGENXBIO INC | $50,672,000 | +2.3% | 1,917,212 | -4.4% | 1.96% | +3.9% |
| New | VENTYX BIOSCIENCES INC | $47,652,000 | – | 1,365,000 | +100.0% | 1.85% | – | |
| IMGN | Sell | IMMUNOGEN INC | $40,860,000 | -0.7% | 8,548,145 | -6.5% | 1.58% | +0.9% |
| NRIX | NURIX THERAPEUTICS INC | $39,177,000 | +2.8% | 3,006,684 | 0.0% | 1.52% | +4.5% | |
| ADCT | ADC THERAPEUTICS SA | $36,208,000 | -39.4% | 7,512,029 | 0.0% | 1.40% | -38.4% | |
| ZYME | Buy | ZYMEWORKS INC | $35,460,000 | +74.4% | 5,765,818 | +50.3% | 1.38% | +77.2% |
| PEN | New | PENUMBRA INC | $33,899,000 | – | 178,792 | +100.0% | 1.32% | – |
| RPTX | Sell | REPARE THERAPEUTICS INC | $32,562,000 | -14.5% | 2,684,396 | -1.3% | 1.26% | -13.1% |
| ANTM | Sell | ELEVANCE HEALTH INC | $32,018,000 | -21.0% | 70,487 | -16.1% | 1.24% | -19.8% |
| SCIENCE 37 HOLDINGS INC | $31,891,000 | -19.9% | 19,808,234 | 0.0% | 1.24% | -18.6% | ||
| PRTA | Sell | PROTHENA CORP PLC | $31,866,000 | +59.4% | 525,575 | -28.6% | 1.24% | +62.0% |
| SYK | New | STRYKER CORPORATION | $31,864,000 | – | 157,321 | +100.0% | 1.24% | – |
| ENTRADA THERAPEUTICS INC | $30,802,000 | +29.4% | 1,954,419 | 0.0% | 1.20% | +31.5% | ||
| MDVL | Buy | MEDAVAIL HOLDINGS INC | $26,853,000 | -30.3% | 34,604,516 | +37.4% | 1.04% | -29.2% |
| OSH | Sell | OAK STR HEALTH INC | $26,023,000 | +14.4% | 1,061,295 | -23.3% | 1.01% | +16.1% |
| ABSCI CORPORATION | $25,137,000 | -5.7% | 8,031,094 | 0.0% | 0.98% | -4.2% | ||
| SKIN | Sell | THE BEAUTY HEALTH COMPANY | $24,872,000 | -62.7% | 2,109,564 | -59.3% | 0.96% | -62.1% |
| ATRA | ATARA BIOTHERAPEUTICS INC | $23,598,000 | -51.5% | 6,242,756 | 0.0% | 0.92% | -50.7% | |
| CNC | Sell | CENTENE CORP DEL | $21,978,000 | -60.1% | 282,460 | -56.6% | 0.85% | -59.5% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $21,760,000 | +16.4% | 3,140,026 | -7.8% | 0.84% | +18.2% |
| ANNX | ANNEXON INC | $21,650,000 | +63.9% | 3,503,190 | 0.0% | 0.84% | +66.7% | |
| AUGX | AUGMEDIX INC | $20,851,000 | -19.4% | 14,380,327 | 0.0% | 0.81% | -18.1% | |
| RAPT | Sell | RAPT THERAPEUTICS INC | $18,883,000 | +26.5% | 784,832 | -4.0% | 0.73% | +28.4% |
| IONS | New | IONIS PHARMACEUTICALS INC | $18,031,000 | – | 407,659 | +100.0% | 0.70% | – |
| GRTS | GRITSTONE BIO INC | $17,869,000 | +6.2% | 6,952,760 | 0.0% | 0.69% | +7.9% | |
| Sell | STEVANATO GROUP S P A | $16,039,000 | -9.1% | 946,825 | -15.1% | 0.62% | -7.7% | |
| ALLK | ALLAKOS INC | $15,577,000 | +95.5% | 2,545,275 | 0.0% | 0.60% | +98.7% | |
| STTK | SHATTUCK LABS INC | $15,174,000 | -33.5% | 5,619,914 | 0.0% | 0.59% | -32.4% | |
| ALVR | Buy | ALLOVIR INC | $15,054,000 | +368.8% | 1,907,969 | +131.7% | 0.58% | +374.8% |
| LVTX | LAVA THERAPEUTICS NV | $12,870,000 | +59.8% | 2,816,196 | 0.0% | 0.50% | +62.0% | |
| RVMD | New | REVOLUTION MEDICINES INC | $12,325,000 | – | 625,000 | +100.0% | 0.48% | – |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $10,858,000 | -25.4% | 81,464 | -12.7% | 0.42% | -24.3% |
| STOK | Sell | STOKE THERAPEUTICS INC | $10,732,000 | -59.2% | 835,830 | -58.1% | 0.42% | -58.6% |
| BVS | Sell | BIOVENTUS INC | $9,094,000 | +2.1% | 1,299,139 | -0.6% | 0.35% | +3.8% |
| CUTR | New | CUTERA INC | $8,873,000 | – | 194,573 | +100.0% | 0.34% | – |
| HUM | New | HUMANA INC | $8,229,000 | – | 16,961 | +100.0% | 0.32% | – |
| Sell | THE ONCOLOGY INSTITUTE INC | $7,330,000 | -16.6% | 1,583,158 | -8.8% | 0.28% | -15.2% | |
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $7,198,000 | +16.0% | 752,097 | -1.9% | 0.28% | +17.7% |
| NUVB | Sell | NUVATION BIO INC | $6,789,000 | -39.6% | 3,031,009 | -12.7% | 0.26% | -38.7% |
| HOOK | HOOKIPA PHARMA INC | $6,113,000 | -17.8% | 4,562,248 | 0.0% | 0.24% | -16.5% | |
| INVIVYD INC | $6,013,000 | -4.6% | 1,920,960 | 0.0% | 0.23% | -3.3% | ||
| NVTA | Sell | INVITAE CORP | $5,610,000 | -39.6% | 2,280,403 | -40.1% | 0.22% | -38.6% |
| Sell | SOMALOGIC INC | $5,425,000 | -42.5% | 1,870,839 | -10.4% | 0.21% | -41.7% | |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $3,634,000 | -10.3% | 1,608,089 | 0.0% | 0.14% | -9.0% | |
| STXS | STEREOTAXIS INC | $2,677,000 | -2.2% | 1,487,495 | 0.0% | 0.10% | -1.0% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $2,200,000 | -37.9% | 3,436,935 | 0.0% | 0.08% | -37.0% | |
| TCRR | TCR2 THERAPEUTICS INC | $1,970,000 | -37.9% | 1,094,645 | 0.0% | 0.08% | -37.2% | |
| TKNO | Sell | ALPHA TEKNOVA INC | $1,864,000 | -60.9% | 558,099 | -1.7% | 0.07% | -60.4% |
| XERIS BIOPHARMA HOLDINGS INC | $1,633,000 | +1.3% | 1,046,587 | 0.0% | 0.06% | +1.6% | ||
| BCEL | ATRECA INC | $1,256,000 | -12.4% | 800,306 | 0.0% | 0.05% | -10.9% | |
| SONENDO INC | $533,000 | -37.8% | 498,131 | 0.0% | 0.02% | -36.4% | ||
| CABA | CABALETTA BIO INC | $453,000 | -38.6% | 696,377 | 0.0% | 0.02% | -35.7% | |
| CTSO | CYTOSORBENTS CORP | $362,000 | -37.9% | 266,365 | 0.0% | 0.01% | -36.4% | |
| AYLA | Exit | AYALA PHARMACEUTICALS INC | $0 | – | -341,030 | -100.0% | -0.01% | – |
| IMTX | Exit | IMMATICS N.V | $0 | – | -449,661 | -100.0% | -0.15% | – |
| PRVA | Exit | PRIVIA HEALTH GROUP INC | $0 | – | -206,113 | -100.0% | -0.23% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -187,460 | -100.0% | -0.42% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -405,517 | -100.0% | -0.68% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -300,000 | -100.0% | -0.95% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -913,319 | -100.0% | -2.78% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -854,013 | -100.0% | -5.77% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.